Taylor Andrew Lawrence Insider Trades

Insider Trading History

Track insider trading activity for Taylor Andrew Lawrence. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $2.51M 629,417 shares
Last Trade
May 28, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.2k 3,076 shares
$3.98
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $2.52M 632,493 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$691k 181,000 shares
$3.82
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.8M 451,493 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.9k 3,452 shares
$4.31
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.82M 454,945 shares
Last Trade
Dec 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$40.5k 8,670 shares
$4.67
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.85M 463,615 shares
Last Trade
Nov 25, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.4k 3,071 shares
$5.35
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.86M 466,686 shares
Last Trade
Sep 17, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$39.6k 16,102 shares
$2.46
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.93M 482,788 shares
Last Trade
Aug 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.1k 2,000 shares
$2.55
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.92M 480,788 shares
Last Trade
Aug 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$208k 80,000 shares
$2.60
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.6M 400,788 shares
Last Trade
Jun 11, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$88.5k 28,172 shares
$3.14
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.71M 428,960 shares
Last Trade
Apr 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 84,000 shares
$2.76
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.38M 344,960 shares
Last Trade
Dec 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.83k 1,000 shares
$4.83
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.37M 343,960 shares
Last Trade
Dec 12, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$173k 34,403 shares
$5.03
$3.99
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Chief Financial Officer
Holding Value $1.51M 378,363 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$488k 100,000 shares
$4.88
$3.99
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Chief Financial Officer
Holding Value $3.71M 278,363 shares
Last Trade
Jul 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.71M 278,363 shares
$13.31
$13.31
Motus GI Holdings
Motus GI Holdings MOTS
Chief Financial Officer
Holding Value $23.1 230,682 shares
Last Trade
Feb 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.9M 95,000 shares
$136.11
$0.00
Motus GI Holdings
Motus GI Holdings MOTS
Chief Financial Officer
Holding Value $13.6 135,682 shares
Last Trade
Nov 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$308k 2,000 shares
$153.99
$0.00
Motus GI Holdings
Motus GI Holdings MOTS
Chief Financial Officer
Holding Value $13.4 133,682 shares
Last Trade
Feb 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64.1M 120,000 shares
$534.00
$0.00
Motus GI Holdings
Motus GI Holdings MOTS
Chief Financial Officer
Holding Value $7.37 73,682 shares
Last Trade
Dec 09, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$327k 1,000 shares
$327.00
$0.00
Motus GI Holdings
Motus GI Holdings MOTS
Chief Financial Officer
Holding Value $8.5 85,000 shares
Last Trade
Nov 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9M 85,000 shares
$222.06
$0.00
Motus GI Holdings
Motus GI Holdings MOTS
Chief Financial Officer
Holding Value $7.8 78,000 shares
Last Trade
Nov 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.3M 78,000 shares
$222.06
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up